Incyte (INCY) Deferred Taxes (2021 - 2026)
Incyte (INCY) posted Deferred Taxes of $63.4 million for Q1 2026, up 569.85% on a QoQ basis from -$13.5 million in Q4 2025, and up 1045.66% year-over-year from $5.5 million in Q1 2025.
Incyte (INCY) Deferred Taxes (2021 - 2026) Analysis & Trends
Incyte's Deferred Taxes history runs 6 years deep, the most recent figure standing at $63.4 million for Q1 2026.
- Quarterly Deferred Taxes rose 1045.66% year-over-year to $63.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$177.6 million (down 498.16% YoY) and the FY2025 annual result came in at -$247.7 million, down 389.51% from the prior year.
- Deferred Taxes was $63.4 million for Q1 2026 at Incyte, up from -$13.5 million in the prior quarter.
- Across five years, Deferred Taxes topped out at $66.0 million in Q4 2023 and bottomed at -$124.1 million in Q3 2025.
- A 5-year average of $181823.5 and a median of -$56000.0 in 2024 frame the typical range for Deferred Taxes.
- Annual changes were most pronounced in 2022 — Deferred Taxes sank 44305.56% — and 2023, when it jumped 1152.37%.
- Incyte's Deferred Taxes stood at -$16.7 million in 2022, then surged by 496.06% to $66.0 million in 2023, then tumbled by 100.08% to -$56000.0 in 2024, then sank by 24001.79% to -$13.5 million in 2025, then jumped by 569.85% to $63.4 million in 2026.
- Business Quant data shows INCY's Deferred Taxes at $63.4 million in Q1 2026, -$13.5 million in Q4 2025, and -$124.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -65.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 96.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Incyte | 23.33 Bn | 19.32 Bn | 1.17 Bn | 63.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63.42 Mn |
| Dec 31, 2025 | -13.50 Mn |
| Sep 30, 2025 | -124.12 Mn |
| Jun 30, 2025 | -103.37 Mn |
| Mar 31, 2025 | -6.71 Mn |
| Dec 31, 2024 | -56,000.00 |
| Sep 30, 2024 | 33.88 Mn |
| Jun 30, 2024 | 17.48 Mn |
| Mar 31, 2024 | 34.25 Mn |
| Dec 31, 2023 | 65.98 Mn |
| Sep 30, 2023 | 31.06 Mn |
| Jun 30, 2023 | 39.70 Mn |
| Mar 31, 2023 | 22.16 Mn |
| Dec 31, 2022 | -16.66 Mn |
| Sep 30, 2022 | -7.96 Mn |
| Jun 30, 2022 | -30.37 Mn |
| Mar 31, 2022 | -2.11 Mn |
| Dec 31, 2021 | 465.43 Mn |
| Sep 30, 2021 | 18,000.00 |
| Jun 30, 2021 | 230,000.00 |